Galera Therapeutics, Inc. (GRTX)
OTCMKTS
· Delayed Price · Currency is USD
0.0450
0.00 (0.00%)
Jan 17, 2025, 4:00 PM EST
Galera Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 8.46 | 18.26 | 4.27 | 19.86 | 15.87 | 18.36 | Upgrade
|
| Short-Term Investments | - | - | 27.33 | 51.36 | 56.9 | 93.93 | Upgrade
|
| Cash & Short-Term Investments | 8.46 | 18.26 | 31.6 | 71.22 | 72.78 | 112.29 | Upgrade
|
| Cash Growth | -70.19% | -42.22% | -55.63% | -2.14% | -35.19% | 37.75% | Upgrade
|
| Other Receivables | - | - | 3.24 | - | - | - | Upgrade
|
| Receivables | - | - | 3.24 | - | - | - | Upgrade
|
| Prepaid Expenses | 0.44 | 3.37 | 3.65 | 6.18 | 5.15 | 5.28 | Upgrade
|
| Restricted Cash | - | - | 0.05 | - | - | - | Upgrade
|
| Total Current Assets | 8.9 | 21.63 | 38.54 | 77.39 | 77.93 | 117.57 | Upgrade
|
| Property, Plant & Equipment | - | 1.28 | 0.48 | 0.82 | 1.55 | 1.75 | Upgrade
|
| Goodwill | - | 0.88 | 0.88 | 0.88 | 0.88 | 0.88 | Upgrade
|
| Other Intangible Assets | - | 2.26 | 2.26 | 2.26 | 2.26 | 2.26 | Upgrade
|
| Other Long-Term Assets | 0 | 0.09 | 1.88 | 1.96 | 1.48 | 0.92 | Upgrade
|
| Total Assets | 8.9 | 26.14 | 44.04 | 83.31 | 84.1 | 123.38 | Upgrade
|
| Accounts Payable | 0.3 | 1.38 | 3.58 | 5.04 | 5.15 | 3.95 | Upgrade
|
| Accrued Expenses | 0.62 | 3.45 | 9.75 | 7.63 | 8.58 | 5.45 | Upgrade
|
| Current Portion of Leases | - | 0.13 | 0.04 | 0.26 | 0.24 | 0.3 | Upgrade
|
| Total Current Liabilities | 0.91 | 4.96 | 13.38 | 12.94 | 13.97 | 9.69 | Upgrade
|
| Long-Term Debt | 151.05 | 151.05 | 139.64 | 128.06 | - | - | Upgrade
|
| Long-Term Leases | - | 1.12 | - | 0.04 | 0.3 | 0.53 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 0.2 | 0.2 | 0.27 | 0.27 | 0.29 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 63.44 | 43.25 | Upgrade
|
| Total Liabilities | 151.96 | 157.33 | 153.22 | 141.32 | 77.98 | 53.77 | Upgrade
|
| Common Stock | 0.05 | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 308.32 | 306.17 | 269.14 | 258.09 | 241.65 | 230.9 | Upgrade
|
| Retained Earnings | -451.43 | -437.41 | -378.32 | -316.1 | -235.57 | -161.35 | Upgrade
|
| Comprehensive Income & Other | - | - | -0.02 | -0.01 | 0.01 | 0.04 | Upgrade
|
| Total Common Equity | -143.06 | -131.19 | -109.18 | -58 | 6.12 | 69.61 | Upgrade
|
| Shareholders' Equity | -143.06 | -131.19 | -109.18 | -58 | 6.12 | 69.61 | Upgrade
|
| Total Liabilities & Equity | 8.9 | 26.14 | 44.04 | 83.31 | 84.1 | 123.38 | Upgrade
|
| Total Debt | 151.05 | 152.3 | 139.68 | 128.37 | 0.53 | 0.83 | Upgrade
|
| Net Cash (Debt) | -142.59 | -134.04 | -108.08 | -57.15 | 72.24 | 111.46 | Upgrade
|
| Net Cash Growth | - | - | - | - | -35.19% | 36.73% | Upgrade
|
| Net Cash Per Share | -2.62 | -3.01 | -3.99 | -2.22 | 2.90 | 30.75 | Upgrade
|
| Filing Date Shares Outstanding | 54.39 | 54.39 | 42.83 | 26.8 | 24.98 | 24.82 | Upgrade
|
| Total Common Shares Outstanding | 54.39 | 54.39 | 28.51 | 26.46 | 24.98 | 24.81 | Upgrade
|
| Working Capital | 7.99 | 16.67 | 25.16 | 64.46 | 63.96 | 107.88 | Upgrade
|
| Book Value Per Share | -2.63 | -2.41 | -3.83 | -2.19 | 0.24 | 2.81 | Upgrade
|
| Tangible Book Value | -143.06 | -134.32 | -112.32 | -61.14 | 2.98 | 66.47 | Upgrade
|
| Tangible Book Value Per Share | -2.63 | -2.47 | -3.94 | -2.31 | 0.12 | 2.68 | Upgrade
|
| Machinery | - | 0.48 | 1.87 | 1.85 | 1.57 | 1.11 | Upgrade
|
| Leasehold Improvements | - | 0.05 | 0.27 | 0.26 | 0.26 | 0.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.